CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Valneva SE - VLA CFD

    5.26
    0.96%
    0.07
    Low: 5.22
    High: 5.33
    Market Trading Hours* (UTC) Opens on Thursday at 08:00

    Mon - Fri: 08:00 - 16:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.07
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.022079 %
    Charges from full value of position ($-4.20)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.022079%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000143 %
    Charges from full value of position ($-0.03)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000143%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency EUR
    Margin 5%
    Stock exchange France
    Commission on trade 0%

    *Information provided by Capital.com

    Valneva SE ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 5.21
    Open* 5.24
    1-Year Change* -19.38%
    Day's Range* 5.22 - 5.33
    52 wk Range 3.95-7.85
    Average Volume (10 days) 754.22K
    Average Volume (3 months) 6.80M
    Market Cap 764.21M
    P/E Ratio -100.00K
    Shares Outstanding 138.77M
    Revenue 223.22M
    EPS -0.96
    Dividend (Yield %) N/A
    Beta 0.57
    Next Earnings Date Mar 21, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 29, 2023 5.26 0.05 0.96% 5.21 5.34 5.21
    Nov 28, 2023 5.21 0.07 1.36% 5.14 5.24 5.09
    Nov 27, 2023 5.17 -0.03 -0.58% 5.20 5.41 5.15
    Nov 24, 2023 5.20 -0.09 -1.70% 5.29 5.31 5.16
    Nov 23, 2023 5.35 -0.12 -2.19% 5.47 5.47 5.10
    Nov 22, 2023 5.48 -0.11 -1.97% 5.59 5.60 5.28
    Nov 21, 2023 5.61 -0.21 -3.61% 5.82 5.84 5.59
    Nov 20, 2023 5.83 0.19 3.37% 5.64 5.88 5.59
    Nov 17, 2023 5.63 0.00 0.00% 5.63 5.78 5.55
    Nov 16, 2023 5.66 -0.04 -0.70% 5.70 5.77 5.63
    Nov 15, 2023 5.77 -0.13 -2.20% 5.90 5.99 5.67
    Nov 14, 2023 5.85 -0.29 -4.72% 6.14 6.14 5.68
    Nov 13, 2023 6.23 -0.22 -3.41% 6.45 6.46 6.23
    Nov 10, 2023 6.32 -0.63 -9.06% 6.95 7.01 6.24
    Nov 9, 2023 6.25 0.30 5.04% 5.95 6.26 5.70
    Nov 8, 2023 5.99 0.09 1.53% 5.90 6.19 5.65
    Nov 7, 2023 5.85 0.31 5.60% 5.54 5.93 5.54
    Nov 6, 2023 5.75 -0.03 -0.52% 5.78 5.90 5.73
    Nov 3, 2023 5.89 0.43 7.88% 5.46 5.92 5.46
    Nov 2, 2023 5.62 0.08 1.44% 5.54 5.79 5.42

    Valneva SE Events

    Time (UTC) Country Event
    Thursday, March 21, 2024

    Time (UTC)

    07:30

    Country

    FR

    Event

    Full Year 2023 Valneva SE Earnings Release
    Full Year 2023 Valneva SE Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 361.303 348.086 110.321 126.196 113.035
    Revenue 361.303 348.086 110.321 126.196 113.035
    Cost of Revenue, Total 324.441 182.22 46.902 49.968 44.448
    Gross Profit 36.862 165.866 63.419 76.228 68.587
    Total Operating Expense 474.746 409.476 165.441 127.007 106.774
    Selling/General/Admin. Expenses, Total 56.499 70.761 45.171 42.277 37.84
    Research & Development 101.322 168.583 61.354 36.783 24.291
    Depreciation / Amortization 4.9 5.4 4.9 4.464 4.331
    Unusual Expense (Income) 0.038 5.742 26.41 0.092 0.007
    Other Operating Expenses, Total -12.454 -23.23 -19.296 -6.577 -4.143
    Operating Income -113.443 -61.39 -55.12 -0.811 6.261
    Interest Income (Expense), Net Non-Operating -31.108 -8.281 -10.182 -0.059 -2.909
    Other, Net -0.264 -0.308 -0.001
    Net Income Before Taxes -144.815 -69.979 -65.302 -0.87 3.351
    Net Income After Taxes -143.279 -73.425 -64.393 -1.744 3.263
    Net Income Before Extra. Items -143.279 -73.425 -64.393 -1.744 3.263
    Net Income -143.279 -73.425 -64.393 -1.744 3.263
    Income Available to Common Excl. Extra. Items -143.279 -73.425 -64.393 -1.744 3.264
    Income Available to Common Incl. Extra. Items -143.279 -73.425 -64.393 -1.744 3.264
    Diluted Net Income -143.279 -73.425 -64.393 -1.744 3.264
    Diluted Weighted Average Shares 115.474 97.6193 90.7572 91.7443 81.6002
    Diluted EPS Excluding Extraordinary Items -1.24079 -0.75216 -0.70951 -0.01901 0.04
    Dividends per Share - Common Stock Primary Issue 0 0 0
    Diluted Normalized EPS -1.10971 -0.71392 -0.51936 -0.01836 0.04008
    Total Adjustments to Net Income 0.001
    Dilution Adjustment 0
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 73.743 33.508 268.079 156.678 93.224
    Revenue 73.743 33.508 268.079 156.678 93.224
    Cost of Revenue, Total 53.838 20.48 152.962 31.247 171.479
    Gross Profit 19.905 13.028 115.117 125.431 -78.255
    Total Operating Expense 108.709 50.082 231.112 63.361 243.634
    Selling/General/Admin. Expenses, Total 43.261 19.024 33.704 12.488 24.095
    Research & Development 25.978 14.065 53.039 23.502 51.883
    Other Operating Expenses, Total -14.441 -3.487 -8.585 -3.876 -3.869
    Operating Income -34.966 -16.574 36.967 93.317 -150.41
    Interest Income (Expense), Net Non-Operating -3.836 -1.673 -12.531 -21.007 -18.577
    Other, Net -0.022 -0.029 -0.235
    Net Income Before Taxes -38.824 -18.247 24.407 72.31 -169.222
    Net Income After Taxes -35.046 -18.127 28.214 72.418 -171.493
    Net Income Before Extra. Items -35.046 -18.127 28.214 72.418 -171.493
    Net Income -35.046 -18.127 28.214 72.418 -171.493
    Income Available to Common Excl. Extra. Items -35.046 -18.127 28.214 72.418 -171.493
    Income Available to Common Incl. Extra. Items -35.046 -18.127 28.214 72.418 -171.493
    Diluted Net Income -35.046 -18.127 28.214 72.418 -171.493
    Diluted Weighted Average Shares 140.184 139.438 122.408 105.991 108.54
    Diluted EPS Excluding Extraordinary Items -0.25 -0.13 0.23049 0.68325 -1.58
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -0.25842 -0.13 0.33638 0.68325 -1.55996
    Unusual Expense (Income) 0.073 -0.008 0.046
    Total Adjustments to Net Income
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 424.66 585.832 308.427 129.162 125.972
    Cash and Short Term Investments 286.532 346.642 204.394 64.439 77.084
    Cash 286.533 346.642 173.109 39.439 57.085
    Cash & Equivalents -0.001 -0.001
    Short Term Investments 31.285 25 20
    Total Receivables, Net 23.912 44.013 19.232 24.03 11.259
    Accounts Receivable - Trade, Net 23.912 44.013 19.232 24.03 11.259
    Total Inventory 35.104 124.098 26.933 25.772 22.727
    Other Current Assets, Total 79.112 71.079 57.868 14.921 14.902
    Total Assets 621.344 817.352 449.164 264.723 229.907
    Property/Plant/Equipment, Total - Net 154.038 173.83 78.153 69.337 37.997
    Property/Plant/Equipment, Total - Gross 221.187 215.283 111.31 100.5 75.012
    Accumulated Depreciation, Total -67.148 -41.453 -33.156 -31.163 -37.015
    Intangibles, Net 28.711 32.7 35.409 41.813 44.891
    Other Long Term Assets, Total 13.935 22.866 25.045 22.148 19.925
    Total Current Liabilities 277.392 368.979 175.87 41.3 42.944
    Accounts Payable 14.505 16.035 24.898 8.868 9.175
    Accrued Expenses 42.724 69.333 24.479 18.323 12.793
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 36.991 10.242 9.684 4.307 17.529
    Other Current Liabilities, Total 183.172 273.369 116.809 9.802 3.447
    Total Liabilities 401.547 646.771 371.742 129.57 86.72
    Total Long Term Debt 115.39 104.413 95.767 80.909 40.07
    Long Term Debt 87.227 50.726 46.375 24.317 14.272
    Capital Lease Obligations 28.163 53.687 49.392 56.592 25.798
    Deferred Income Tax 0.694 1.29 0.412
    Other Liabilities, Total 8.071 172.089 99.693 7.361 3.706
    Total Equity 219.797 170.581 77.422 135.153 143.187
    Common Stock 20.755 15.786 13.646 13.642 13.638
    Additional Paid-In Capital 594.043 409.258 244.984 297.732 297.72
    Retained Earnings (Accumulated Deficit) -389.315 -248.671 -177.835 -170.272 -161.559
    Treasury Stock - Common -0.645 -0.645 -0.898 -1.112 -1.133
    Other Equity, Total -5.041 -5.147 -2.475 -4.837 -5.479
    Total Liabilities & Shareholders’ Equity 621.344 817.352 449.164 264.723 229.907
    Total Common Shares Outstanding 138.223 105.115 90.8242 90.8195 90.7935
    Total Preferred Shares Outstanding 0.02051 17.8367 17.8367 17.8367 17.8367
    Long Term Investments 0 2.124 2.13 2.263 1.122
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 320.653 341.48 389.329 424.66 476.535
    Cash and Short Term Investments 171.253 204.411 254.485 286.532 261.042
    Cash & Equivalents 171.253 204.411 254.485 -0.001 261.042
    Total Receivables, Net 44.346 33.669 27.018 23.912 57.732
    Accounts Receivable - Trade, Net 44.346 33.669 27.018 23.912 57.732
    Total Inventory 38 33.353 38.999 35.104 96.462
    Other Current Assets, Total 67.054 70.047 68.827 79.112 61.299
    Total Assets 520.539 542.571 590 621.344 698.083
    Property/Plant/Equipment, Total - Net 156.133 156.1 158.039 154.038 170.659
    Intangibles, Net 26.341 27.125 27.896 28.711 29.652
    Long Term Investments 0 0
    Other Long Term Assets, Total 17.412 17.866 14.736 13.935 21.237
    Total Current Liabilities 218.151 241.043 263.26 277.392 374.211
    Payable/Accrued 94.241 33.52 41.491 74.973
    Accrued Expenses 14.496 41.524 15.875 15.738 16.036
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 59.605 47.134 39.944 36.991 15.612
    Other Current Liabilities, Total 49.809 108.249 173.921 183.172 267.59
    Total Liabilities 363.018 351.864 385.217 401.547 533.1
    Total Long Term Debt 134.898 102.098 112.784 115.39 146.007
    Long Term Debt 107.047 74.216 83.228 87.227 93.364
    Capital Lease Obligations 27.851 27.882 29.556 28.163 52.643
    Deferred Income Tax 2.22 0.971 1.057 0.694 1.784
    Other Liabilities, Total 7.749 7.752 8.116 8.071 11.098
    Total Equity 157.521 190.707 204.783 219.797 164.983
    Common Stock 20.837 20.834 20.752 20.755 17.603
    Additional Paid-In Capital 594.003 593.96 594.043 594.043 501.638
    Retained Earnings (Accumulated Deficit) -457.319 -424.088 -410.011 -389.315 -354.258
    Other Equity, Total 0.001 -0.001 -5.041
    Total Liabilities & Shareholders’ Equity 520.539 542.571 590 621.344 698.083
    Total Common Shares Outstanding 138.772 138.772 138.223 138.223 117.276
    Total Preferred Shares Outstanding 0.02051 0.02051 0.02051
    Cash 286.533
    Short Term Investments
    Treasury Stock - Common -0.645
    Accounts Payable 44.136
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -143.279 -73.425 -64.393 -1.744 3.264
    Cash From Operating Activities -242.445 76.945 137.779 5.529 16.306
    Cash From Operating Activities 21.036 14.281 9.799 8.532 6.828
    Non-Cash Items -126.058 101.55 116.613 7.769 3.534
    Cash Taxes Paid 0.154 1.631 2.021 2.346 1.273
    Cash Interest Paid 9.211 8.417 4.711 2.621 4.165
    Changes in Working Capital 5.856 34.539 75.76 -9.028 2.68
    Cash From Investing Activities -29.054 -93.116 -19.34 -10.685 -2.917
    Capital Expenditures -29.322 -93.171 -19.471 -10.884 -3.171
    Other Investing Cash Flow Items, Total 0.268 0.055 0.131 0.199 0.254
    Cash From Financing Activities 215.116 154.504 21.74 -7.696 30.945
    Financing Cash Flow Items -9.211 -8.417 -4.71 -2.621 -4.165
    Issuance (Retirement) of Stock, Net 189.837 166.823 0.29 -2.463 49.263
    Issuance (Retirement) of Debt, Net 34.49 -3.902 26.16 -2.612 -14.153
    Foreign Exchange Effects -0.828 3.96 -0.183 0.207 -0.795
    Net Change in Cash -57.211 142.293 139.996 -12.645 43.539
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -18.127 -143.279 -99.075 -171.493 -26.041
    Cash From Operating Activities -24.326 -242.445 -186.562 -100.18 -26.806
    Non-Cash Items 8.438 -126.058 17.784 -5.481 -6.922
    Cash Taxes Paid 0.433 0.154 1.082 0.818 0.318
    Cash Interest Paid 2.689 9.211 6.544 4.054 1.909
    Changes in Working Capital -14.637 5.856 -105.271 65.641 6.157
    Cash From Investing Activities -3.561 -29.054 -22.483 -15.994 -9.447
    Capital Expenditures -3.814 -29.322 -22.541 -16.028 -9.461
    Other Investing Cash Flow Items, Total 0.253 0.268 0.058 0.034 0.014
    Cash From Financing Activities -3.816 215.116 121.631 105.006 0.982
    Financing Cash Flow Items -2.689 -9.211 -6.544 -4.054 -1.909
    Issuance (Retirement) of Stock, Net -0.194 189.837 93.998 94.308 3.726
    Issuance (Retirement) of Debt, Net -0.933 34.49 34.177 14.752 -0.835
    Foreign Exchange Effects -0.344 -0.828 1.814 0.751 -0.107
    Net Change in Cash -32.047 -57.211 -85.6 -10.417 -35.378
    Cash From Operating Activities 21.036 11.153
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Grimaud Family Other Insider Investor 9.51 13209067 0 2023-07-31 LOW
    Bpifrance Participations S.A. Sovereign Wealth Fund 9.2164 12801207 1184386 2023-06-20 LOW
    CDC Entreprises Valeurs Moyennes Investment Advisor 8.56 11889549 -875049 2023-07-31 LOW
    Pfizer Inc Corporation 6.87 9542196 -13890 2023-07-31 LOW
    Deep Track Capital LP Hedge Fund 6.55 9097727 -1416746 2023-07-31 MED
    Polar Capital LLP Investment Advisor/Hedge Fund 3.6343 5047974 -37561 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.0466 2842624 1025 2023-09-30 LOW
    Medical Strategy GmbH Investment Advisor 1.5495 2152225 0 2023-05-31 MED
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 1.4732 2046160 2046160 2022-12-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.2716 1766167 27679 2023-09-30 LOW
    Valneva SE Employees Corporation 0.92 1277849 0 2023-07-31
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.2977 413482 -5274 2023-09-30 LOW
    HSBC Global Asset Management (France) S.A. Investment Advisor 0.2212 307237 -40571 2022-12-31 LOW
    General American Investors Company, Inc. Investment Advisor 0.1607 223201 0 2023-06-30 LOW
    Fubon Asset Management Company Ltd. Investment Advisor 0.148 205513 -4390 2023-07-31 MED
    ÖKOWORLD LUX S.A. Investment Advisor 0.144 200000 200000 2022-06-30 LOW
    AXA Investment Managers Paris Investment Advisor/Hedge Fund 0.1417 196769 0 2023-08-31 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1395 193740 -372 2023-09-30 LOW
    Charles Schwab Investment Management, Inc. Investment Advisor 0.1379 191558 0 2023-09-30 LOW
    La Française AM Investment Advisor 0.126 175000 25000 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Valneva SE Company profile

    About Valneva SE

    Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.

    Financial summary

    BRIEF: For the six months ended 30 June 2021, Valneva SE revenues decreased 1% to EUR47.5M. Net loss applicable to common stockholders increased from EUR25.6M to EUR86.4M. Revenues reflect Commercialized Vaccines segment decrease of 22% to EUR31.8M, Canada segment decrease of 75% to EUR2M, United Kingdom segment decrease of 75% to EUR1.1M, Europe excluding France segment decrease of 42% to EUR4.2M.

    Equity composition

    07/2010, Rights Issue, 2 new shares for every 5 shares held @ EUR 5.06 (Factor: 1.12817). 6/2013, Rights Issue, 5 new shares for every 13 shares held @ EUR2.65 (Factor: 1.11881). 1/2015, Rights Issue, 11 new shares for every 34 shares held @ EUR2.47 (Factor: 1.10896).

    Industry: Biotechnology & Medical Research (NEC)

    6 rue Alain Bombard
    SAINT-HERBLAIN
    PAYS DE LA LOIRE 44800
    FR

    Income Statement

    • Annual
    • Quarterly

    News

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    Gold Rises as Traders price-in Fed Rate Cuts

    Gold prices have declined despite a drop in Treasury yields and a weaker US Dollar. We look at the key drivers and technical levels for the gold price.

    13:17, 20 November 2023

    People also watch

    Oil - Crude

    77.87 Price
    +1.630% 1D Chg, %
    Long position overnight fee -0.0164%
    Short position overnight fee -0.0055%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    XRP/USD

    0.61 Price
    -0.320% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    Gold

    2,045.91 Price
    +0.240% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.30

    US100

    16,022.10 Price
    +0.090% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading